Indaptus Therapeutics, Inc.
INDP
$6.52
-$0.55-7.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.96M | -15.75M | -15.02M | -14.89M | -15.75M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 700.00 | 1.00K | 1.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.96M | 1.77M | 2.31M | 2.75M | 2.93M |
| Change in Net Operating Assets | 29.70K | 541.90K | 392.30K | 616.10K | 67.70K |
| Cash from Operations | -14.97M | -13.43M | -12.32M | -11.53M | -12.75M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 7.00M |
| Cash from Investing | -- | -- | -- | 0.00 | 7.00M |
| Total Debt Issued | 5.71M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.19M | 8.66M | 5.51M | 3.38M | 375.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.08M | -1.07M | -762.70K | -429.50K | -21.50K |
| Cash from Financing | 13.83M | 7.58M | 4.75M | 2.95M | 354.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.14M | -5.85M | -7.58M | -8.58M | -5.40M |